ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993